Tempus Co-Founder Eric Lefkofsky Secures Another $80 Million in Funding For Data-Driven Research Technology

Posted on May 15, 2018 By

March Funding

Chicago tech startup, Tempus, defied funding expectations when it was announced in March that another $80 had been secured in funding. The primary investor behind this latest funding was T. Rowe Price, an investment firm that focuses on technology startups. This came just 6 months after a $70 million funding announcement and is the 6th round of funding since the company’s launch in 2015. Including this round in March, the company is now backed by $210 million and the total company value stands upwards of $1.1 billion. These are impressive numbers for a startup, making Tempus a tech company Chicago can be proud of.

Applying the Funds

According to a Tempus spokesperson, this round of funding will be used primarily for expanding and further developing their clinical and analytical platforms. A portion of the funds will also be used to bring on additional employees. Tempus’ hiring page calls for ‘the smartest people on the planet’ who are driven to pursue excellence. Their non-stop company expansion makes it easy to believe that they are finding the intelligence and passion they are looking for.

About Tempus

Co-founded in 2015 by Detroit native Eric Lefkofsky, Tempus uses in-depth scientific data and analytics to provide genetic sequencing for tumors. There are a number of ways this is being accomplished, from in-depth imaging to data patterns and output. Tempus is building a library that will house this information – a library that becomes more refined and precise with each addition to the files. This database of specialized information allows physicians to better understand their patient’s unique makeup and lends insight for developing specialized treatment plans.

About Eric Lefkofsky

Hailing from Detroit, Michigan, Eric has always managed his investments well. It isn’t a surprise either, that he co-founded Tempus. Nearly 10 years prior, Eric and his wife Liz founded the Lefkofsky Family Foundation with one of the goals being to propel innovative medical research. Stemming from that desire to impact the medical field, Tempus was born to help provide physicians and their patients with relevant, actionable data using modern technological advancements.

 

Business LeadersInvestment Firm